Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients

scientific article published in May 1998

Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0049-3848(98)00050-4
P698PubMed publication ID9692617
P5875ResearchGate publication ID13591875

P2093author name stringShenkman B
Savion N
Varon D
Knobler H
Kotev-Emeth S
P2860cites workCollaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' CollaborationQ29619529
The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stressQ34182746
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplastyQ34336722
Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease StudyQ35009072
The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplastyQ37694282
Evaluation of the clinical utility of platelet aggregation studiesQ38897612
Platelet lipoprotein interactionsQ39530368
Do platelets have anything to do with diabetic microvascular disease?Q40119288
Platelets in diabetes: the role in the hemostatic regulation in atherosclerosisQ40837696
Potential mechanisms promoting restenosis in diabetic patientsQ40973029
Platelet hyperreactivity and prognosis in survivors of myocardial infarctionQ41229453
Thromboxane biosynthesis and platelet function in type I diabetes mellitusQ41429378
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialQ44459441
A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditionsQ45880969
Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group.Q51010819
Can restenosis after coronary angioplasty be predicted from clinical variables?Q52228108
Increased Platelet Aggregation in Early Diabetus MellitusQ66941531
Effects of dietary and pharmacologic alteration of serum lipids on platelet survival timeQ67352454
The effect of antihypertensive drugs on in vivo platelet activity in essential hypertensionQ67516409
Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young menQ67730473
Platelet abnormalities in diabetes mellitusQ68046313
Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitusQ70555895
Platelet function in diabetes mellitusQ71503473
Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable anginaQ71971760
A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathyQ72408304
Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitroQ72520278
Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patientsQ72727482
The influence of lipoproteins on blood plateletsQ72940230
Are we mortgaging the medical profession?Q95814757
P433issue4
P304page(s)181-190
P577publication date1998-05-01
P1433published inThrombosis ResearchQ15758741
P1476titleShear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients
P478volume90

Reverse relations

cites work (P2860)
Q54057930Abciximab reduces mortality in diabetics following percutaneous coronary intervention.
Q44371721Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus
Q28193753Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
Q26823633Assessment of platelet inhibition by point-of-care testing in neuroendovascular procedures
Q33629000Barriers to Implementing an Insulin Order Form In a Non-ICU Medical Unit.
Q52355379Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets.
Q36567704Determination of normal range of bleeding time in rural and urban residents of Borujerd, Iran: A pilot study
Q37588694Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases
Q37858336Endoplasmic-reticulum calcium depletion and disease
Q35854008Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations.
Q55045262In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.
Q51554134Increased plasma endothelin-1 and intraplatelet cyclic guanosine monophosphate in men with disturbed glucose metabolism.
Q24800363Influence of diabetes mellitus on heart failure risk and outcome
Q50019585Long-term Prognosis and Clinical Characteristics of Patients with Newly Diagnosed Diabetes Mellitus Detected after First Acute Myocardial Infarction: from KAMIR-NIH Registry
Q51243894Maternal selective serotonin reuptake inhibitor intake does not seem to affect neonatal platelet function tests.
Q28196731Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects
Q28193664Optimizing the diabetic formulary: beyond aspirin and insulin
Q36320564Pathobiology and cell interactions of platelets in diabetes
Q35813673Percutaneous coronary intervention in diabetics
Q28186087Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense
Q36052944Recurrent vascular events in lacunar stroke patients with metabolic syndrome and/or diabetes
Q24793107Risk factors in coronary atherosclerosis athero-inflammation: the meeting point
Q46313799Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)].
Q74238336Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor
Q35584004The Role of Glycoprotein IIb/IIIa-Receptor Antagonists in Diabetics
Q37798968The role of calpain in diabetes-associated platelet hyperactivation.
Q33870602The role of plaque rupture and thrombosis in coronary artery disease
Q33998463The role of platelets in diabetes-related vascular complications